VISHEE(SH:688580)2025-02-26 08:00Financial Performance - Total revenue for 2024 was CNY 400.06 million, a decrease of 13.45% compared to the previous year[3] - Operating profit decreased by 26.48% to CNY 109.13 million, while total profit fell by 26.02% to CNY 111.00 million[3] - Net profit attributable to shareholders was CNY 100.01 million, down 26.61% year-on-year, with a net profit excluding non-recurring gains and losses of CNY 83.80 million, a decline of 31.15%[3] - Basic earnings per share decreased by 26.30% to CNY 1.0509, and the weighted average return on equity dropped by 2.49 percentage points to 6.14%[3] Assets and Equity - Total assets at the end of the reporting period were CNY 1,818.52 million, an increase of 0.69% year-on-year, while equity attributable to shareholders decreased by 0.08% to CNY 1,625.50 million[5] - The company's share capital increased by 39.56% due to a capital reserve conversion plan, resulting in a significant increase in the number of shares[7] Product and Market Strategy - The company achieved good sales results for its aesthetic medical products, including the shaping magnetic stimulation device and high-frequency electrosurgical device[6] - The company is focused on optimizing its marketing system to enhance market share in rehabilitation and expand sales of aesthetic medical products[6] - The company continues to promote technological innovation and product upgrades, successfully obtaining certifications for new devices[6] Investor Advisory - Investors are advised to be cautious as the financial data is preliminary and unaudited, with final figures to be disclosed in the annual report[9]